Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test
04:03 EDT 25 Jul 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
CARLSBAD, Calif., July 25, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announced the acquisition of Pinpoint Genomics, Inc., and its early-stage non-small cell lung cancer test that can help doctors identify those early-sta...
Other Sources for this Article
More From BioPortfolio on "Life Technologies Acquires Pinpoint Genomics and CLIA-Approved Lung Cancer Test"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
